Regular Article
Adhesion of Lymphoid Cells to CD44-Specific Substrata: The Consequences of Attachment Depend on the Ligand

https://doi.org/10.1006/excr.2000.4852Get rights and content

Abstract

Interactions between cell-surface adhesion receptors and immobilized specific substrata can exert profound effects on cell morphology. Using phase-contrast microscopy, we show that CD44-expressing mouse lymphoid cells display a spread morphology when adhering to CD44-specific monoclonal antibody (mAb) immobilized on plastic. This spread morphology is different from that of these same cells when adhering to immobilized hyaluronan, the natural ligand of CD44. Morphometric measurements, in combination with intracellular actin staining and fluorescence microscopy, revealed that the adhesion of lymphoid cells to hyaluronan required essentially no cytoskeletal reorganization and resulted in no fundamental change in morphology. On the other hand, cells adhering to immobilized CD44-specific mAb rearranged their actin structure and established multiple membrane contact sites (spread). Cell spreading on antibody, but not attachment to hyaluronan, was inhibited by cytoskeleton-disrupting agents. Transfection of CD44-negative lymphoid cells with full-length and tailless CD44 enabled these cells to bind to both immobilized hyaluronan and mAb. However, the transfectant lacking the cytoplasmic tail of CD44 spread only transiently on the antibody-coated surface. Our results suggest that CD44 may mediate lymphocyte attachment to its carbohydrate ligand hyaluronan by mechanisms broadly similar to those used by selectins. When immobilized CD44-specific antibody is the ligand, however, CD44 may regulate the activity of the cytoskeleton by mechanisms broadly similar to those used by integrins. In the latter case, the cytoplasmic domain of CD44 contributes to cell spreading.

References (45)

  • T.A. Springer

    Cell

    (1994)
  • M.B. Lawrence et al.

    Cell

    (1991)
  • B.M. Gumbiner

    Cell

    (1996)
  • P. Sánchez-Mateos et al.

    Semin. Cancer Biol.

    (1996)
  • J. Lesley et al.

    Adv. Immunol.

    (1993)
  • P. Herrlich et al.

    Immunol. Today

    (1993)
  • A. Aruffo et al.

    Cell

    (1990)
  • N.C. Brissett et al.

    FEBS Lett.

    (1996)
  • J. Bajorath et al.

    J. Biol. Chem.

    (1998)
  • B. Haimovich et al.

    J. Biol. Chem.

    (1993)
  • B.M. Sandmaier et al.

    Blood

    (1998)
  • T.L. Waddell et al.

    J. Biol. Chem.

    (1995)
  • J.W. Legg et al.

    Curr. Biol.

    (1998)
  • L. Santos-Argumedo et al.

    Immunology

    (1997)
  • R.L. Juliano et al.

    J. Cell Biol.

    (1993)
  • T.F. Tedder et al.

    FASEB J.

    (1995)
  • E. Crockett-Torabi et al.

    Immunol. Res.

    (1995)
  • E.A. Clark et al.

    Science

    (1995)
  • S. Miyamoto et al.

    Science

    (1995)
  • I.S. Trowbridge et al.

    Immunogenetics

    (1982)
  • S.C. Wheatley et al.

    Development

    (1993)
  • J. Lesley et al.

    J. Exp. Med.

    (1994)
  • Cited by (19)

    • Interleukin-1β-induced reduction of CD44 Ser-325 phosphorylation in human epidermal keratinocytes promotes CD44 homomeric complexes, binding to ezrin, and extended, monocyte-adhesive hyaluronan coats

      2015, Journal of Biological Chemistry
      Citation Excerpt :

      To explore whether IL-1β induced similar changes in keratinocytes, we performed a scratch wound assay. However, IL-1β did not significantly influence the migratory activity of the keratinocytes (Fig. 6A), suggesting that a robust migration would require additional changes, perhaps enhanced synthesis of hyaluronan (49, 50) or its fixation to substratum (48, 51, 52). Because the hyaluronan coat on keratinocytes was enlarged by IL-1β, we next checked whether this influenced hyaluronan-dependent monocyte binding to the cells.

    • Role of the extracellular and cytoplasmic domains of CD44 in the rolling interaction of lymphoid cells with hyaluronan under physiologic flow

      2003, Journal of Biological Chemistry
      Citation Excerpt :

      Both preparations contain high molecular-weight HA (∼1 × 103 and 4 × 103 kDa for umbilical cord HA and Healon®, respectively). Rat monoclonal antibodies (mAb) specific for mouse CD44 IM7.8.1 (referred to as IM7) and IRAWB14 (28-30) were purified from ascites fluid on protein G-Sepharose (Amersham Biosciences, Piscataway, NJ) as described (31, 32). Conjugation of antibodies with biotin (Pierce, Rockford, IL) or Alexa Fluor 594 (Molecular Probes, Eugene, OR) was performed according to the manufacturers' instructions.

    • Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6

      2002, Journal of Biological Chemistry
      Citation Excerpt :

      The AKR1 cell line is a CD44-negative T lymphoma that binds HA constitutively when transfected with wild-type CD44 (59). CTLL-2 is a CD44-negative cytotoxic T cell line that also binds HA constitutively when transfected with CD44 (39). XJ(3)/CD44− is a CD44-negative variant of a pre-B cell line that, when transfected with wild-type CD44, shows an “inducible” HA binding phenotype (37).

    View all citing articles on Scopus
    1

    To whom correspondence and reprint requests should be addressed at Department of Orthopedic Surgery, Rush–Presbyterian–St. Luke's Medical Center, 1653 West Congress Parkway, Chicago, IL 60612. Fax: (312) 942-2101. E-mail: [email protected].

    View full text